ES2107212T3 - Derivados de 1,4-benzoxazina como abridores de los canales de potasio. - Google Patents

Derivados de 1,4-benzoxazina como abridores de los canales de potasio.

Info

Publication number
ES2107212T3
ES2107212T3 ES94913764T ES94913764T ES2107212T3 ES 2107212 T3 ES2107212 T3 ES 2107212T3 ES 94913764 T ES94913764 T ES 94913764T ES 94913764 T ES94913764 T ES 94913764T ES 2107212 T3 ES2107212 T3 ES 2107212T3
Authority
ES
Spain
Prior art keywords
potassium channel
channel openers
benzoxazine derivatives
fluorated
sup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94913764T
Other languages
English (en)
Inventor
Frederick Jeffrey Brown
Keith Russell
Paul James Warwick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ES2107212T3 publication Critical patent/ES2107212T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

COMPUESTOS DE FORMULA (I), DONDE R 1 Y R 2 SE SELECCIONAN INDEPENDIENTEMENTE DE (1-3C) ALQUILO QUE PUEDE SER SUSTITUIDO POR UNO O MAS GRUPOS FLUORADOS, SIEMPRE QUE AL MENOS UNO DE R{SUP,1} Y R{SUP,2} ESTE SUSTITUIDO POR AL MENOS UN GRUPO FLUORADO; Y QUE LAS SALES FARMACEUTICAMENTE ACEPTABLES SEAN UTILES COMO ABRIDORES DEL CANAL DE POTASIO PARA EL TRATAMIENTO DE LA INCONTINENCIA URINARIA. TAMBIEN SE PRESENTAN LAS COMPOSICIONES FARMACEUTICAS, LOS PROCESOS PARA LA PREPARACION DE LAS COMPOSICONES DE LA FORMULA (I) Y SUS COMPUESTOS INTERMEDIOS.
ES94913764T 1993-05-12 1994-05-04 Derivados de 1,4-benzoxazina como abridores de los canales de potasio. Expired - Lifetime ES2107212T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939309716A GB9309716D0 (en) 1993-05-12 1993-05-12 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
ES2107212T3 true ES2107212T3 (es) 1997-11-16

Family

ID=10735294

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94913764T Expired - Lifetime ES2107212T3 (es) 1993-05-12 1994-05-04 Derivados de 1,4-benzoxazina como abridores de los canales de potasio.

Country Status (9)

Country Link
US (2) US5486515A (es)
EP (1) EP0698022B1 (es)
JP (1) JP3523257B2 (es)
AU (1) AU6579494A (es)
DE (1) DE69405729T2 (es)
ES (1) ES2107212T3 (es)
GB (1) GB9309716D0 (es)
HU (1) HU9501708D0 (es)
WO (1) WO1994026739A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
GB9607458D0 (en) * 1996-04-10 1996-06-12 Zeneca Ltd Enzymatic process for stereoselective preparation of therapeutic amides
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
GB9804648D0 (en) 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
JP2003508509A (ja) 1999-09-04 2003-03-04 アストラゼネカ アクチボラグ ピルビン酸デヒドロゲナーゼの阻害剤としてのアミド
MXPA02002319A (es) 1999-09-04 2002-07-30 Astrazeneca Ab Derivados 2-hidroxi-2-metil-3,3,3-trifluoropropanamida con n-fenilo susbtituido que elevan la actividad de la deshidrogenasa de piruvato.
ES2273725T3 (es) 1999-09-04 2007-05-16 Astrazeneca Ab Derivados de hidroxiacetamidobencenosulfonamida.
AU781365B2 (en) 1999-12-21 2005-05-19 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) * 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6620849B2 (en) 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
JP2004528335A (ja) 2001-04-23 2004-09-16 アストラゼネカ アクチボラグ 血管新生の治療に使用のベンゾオキサジノン誘導体
GB0120471D0 (en) * 2001-08-23 2001-10-17 Astrazeneca Ab Chemical compounds
KR100823805B1 (ko) * 2004-05-05 2008-04-21 에프. 호프만-라 로슈 아게 5-ｈｔ6 수용체, 5-ｈｔ2ａ 수용체 또는 둘다를 조절하기에유용한 아릴설포닐 벤조다이옥산
US7378415B2 (en) 2004-09-30 2008-05-27 Roche Palo Alto Llc Benzoxazine and quinoxaline derivatives and uses thereof
JP5903499B2 (ja) 2011-12-22 2016-04-13 ノバルティス アーゲー ジヒドロ−ベンゾ−オキサジンおよびジヒドロ−ピリド−オキサジン誘導体
CN112511569B (zh) * 2021-02-07 2021-05-11 杭州筋斗腾云科技有限公司 网络资源访问请求的处理方法、系统及计算机设备

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3225042A (en) * 1962-07-31 1965-12-21 Lilly Co Eli Hydroxymorpholines
US3192208A (en) * 1962-07-31 1965-06-29 Lilly Co Eli Novel substituted morpholines and piperazines and processes for their synthesis
US3763153A (en) * 1972-02-22 1973-10-02 Squibb & Sons Inc Benzothiazines
US3821377A (en) * 1972-02-22 1974-06-28 Squibb & Sons Inc Anti-inflammatory agents
JPS62178577A (ja) * 1986-02-03 1987-08-05 Daikin Ind Ltd 含フツ素複素環化合物
CA1304082C (en) * 1987-10-22 1992-06-23 Tetsuya Tahara Benzoxazine compounds and pharmaceutical use thereof
TW224941B (es) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd
CN1060467A (zh) * 1990-09-25 1992-04-22 武田药品工业株式会社 1，3-苯并嗪衍生物、其生产方法和用途
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
AU1493092A (en) * 1991-04-18 1992-10-22 Ortho Pharmaceutical Corporation (+) and (-) enantiomers of 5-aliphatic-6-(benzoxazinyl- or benzothiazinyl)-2,3,4,5-tetrahydropyridazin-3-ones
ATE191716T1 (de) * 1992-08-17 2000-04-15 Chugai Pharmaceutical Co Ltd Benzopyran und benzoxazin-derivate
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives

Also Published As

Publication number Publication date
EP0698022A1 (en) 1996-02-28
HU9501708D0 (en) 1996-03-28
AU6579494A (en) 1994-12-12
WO1994026739A1 (en) 1994-11-24
GB9309716D0 (en) 1993-06-23
US5700798A (en) 1997-12-23
US5486515A (en) 1996-01-23
DE69405729T2 (de) 1998-01-08
JP3523257B2 (ja) 2004-04-26
JPH08510226A (ja) 1996-10-29
EP0698022B1 (en) 1997-09-17
DE69405729D1 (de) 1997-10-23

Similar Documents

Publication Publication Date Title
ES2107212T3 (es) Derivados de 1,4-benzoxazina como abridores de los canales de potasio.
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
EA200200509A1 (ru) Новые производные бензоимидазола, используемые в качестве антипролиферативного средства
TR200003478T2 (tr) Antikanser maddeleri olarak faydalı izotiyazol türevleri
UY26143A1 (es) Derivados heterocíclicos útiles como agentes anticancerosos
DK0679157T3 (da) Nye 3,4-diarylthiophener og analoge deraf til anvendelse som antiinflammatoriske midler
ECSP941096A (es) Procedimiento para la preparacion de un derivado indol
TR200000671T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
BR9713186A (pt) Inibidores de metaloprotease 1,3-diheterocìclicos
TR200000670T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
ATE346058T1 (de) Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
PA8593101A1 (es) Composiciones para el tratamiento de crecimiento celular anormal
LU91362I2 (fr) Palipéridone et ses dérivés pharmaceutiquement acceptables (INVEGA)
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
EA200500174A1 (ru) Новые производные бензимидазола, полезные в качестве антипролиферативных агентов
TR200000673T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
DK0556329T3 (da) Substituerede piperaziner som midler til behandling af centralnervesystemet
NO981250D0 (no) Nye derivater av cyklodepsipeptid PF1022-substans
AR009145A1 (es) Compuetos heterociclicos de guanidinilo utiles como agonistas de alfa-2 adrenoreceptores y composiciones farmaceuticas que los comprenden
MX9602979A (es) Compuestos heterociclicos terapeuticos.
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
PY2167570A (es) Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmacéuticos de los mismos
ES2109276T3 (es) Derivados de tropolona y composicion farmaceutica de los mismos para prevenir y tratar enfermedades isquemicas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 698022

Country of ref document: ES